Sitemap > Breaking Research > Cardiovascular Disorders
Displaying 1601 - 1650 of 4862 results
- Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease.
- Particularities of the vasculature can promote the organ specificity of autoimmune attack.
- The neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential.
- Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats.
- Decreased mortality in a rat model of acute postinfarction heart failure.
- Vascular endothelial growth factor C-induced collateral formation in a model of myocardial ischemia.
- Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial.
- Mechanisms of hypertension associated with BAY 43-9006.
- Glycoprotein IIb/IIIa inhibitors during rescue percutaneous coronary intervention in acute myocardial infarction.
- Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations.
- Role of angiotensin II receptor blockers in atherosclerotic plaque stability.
- Early pharmacological preconditioning by erythropoietin mediated by inducible NOS and mitochondrial ATP-dependent potassium channels in the rat heart.
- Reduced expression of endothelial connexins 43 and 37 in hypertensive rats is rectified after 7-day carvedilol treatment.
- Longitudinal study on hypertension control in primary care: the Insubria study.
- The metabolic syndrome and cardiovascular disease.
- Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome.
- Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non-valvular atrial fibrillation. Pooled analysis from the SPORTIF III and V studies.
- Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project.
- Dobutamine stress echocardiography can predict reversible ventricular dysfunction after acute myocardial infarction.
- Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.
- HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk.
- Erectile dysfunction and statin treatment in high cardiovascular risk patients.
- Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases.
- Suppression of apoptosis in the protein kinase Cdelta null mouse in vivo.
- Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.
- Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A.
- Purified human bone marrow multipotent mesenchymal stem cells regenerate infarcted myocardium in experimental rats.
- Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial.
- Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis.
- Intracoronary delivery of an adenovirus encoding fibroblast growth factor-4 in myocardial ischemia: effect of serum antibodies and previous exposure to adenovirus.
- Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats.
- Synthesis and pharmacological evaluation of some N-arylsulfonyl-N-methyl-N'-(2,2-dimethyl-2H-1-benzopyran-4-yl)ureas structurally related to cromakalim.
- Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM.
- Relapse and mortality following cardioversion of new-onset vs. recurrent atrial fibrillation and atrial flutter in the elderly.
- Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia.
- Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice.
- Norbornyllactone-substituted xanthines as adenosine A(1) receptor antagonists.
- Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis.
- Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial.
- The role of risk stratification in the decision to provide upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes: a cost-effectiveness analysis.
- Predictors of adverse outcome among patients with hypertension and coronary artery disease.
- Tibolone improves myocardial perfusion in postmenopausal women with ischemic heart disease: an open-label exploratory pilot study.
- Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure.
- Chronic recurrent myocardial ischemic injury is significantly attenuated by pre-emptive adeno-associated virus heme oxygenase-1 gene delivery.
- Risk stratification of in-hospital mortality for coronary artery bypass graft surgery.
- Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease.
- Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.
- Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study.
- Women and cardiovascular heart disease: clinical implications from the Women's Ischemia Syndrome Evaluation (WISE) Study. Are we smarter?
- Women and ischemic heart disease: pathophysiologic implications from the Women's Ischemia Syndrome Evaluation (WISE) Study and future research steps.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 Next >